Ozempic: How 'mercenary' start-up Eucalyptus scored $100m selling breakout drug
Eucalyptus could have been a Millennial house of brands but instead it hitched its wagon to the breakout drug of 2023, triggering controversy and sales.
Stay updated with breaking news from Michael Quelch. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Eucalyptus could have been a Millennial house of brands but instead it hitched its wagon to the breakout drug of 2023, triggering controversy and sales.
As any good negotiator will tell you, the best time to do a deal is right before the certainty has set in. In this case, the complete opposite is true.
The year ended with a lecture from the mining establishment, but not before a carry-on of CEOs joined the unemployment queue.
Policy-makers need to heed the calls by two prominent female resource sector leaders not to hobble the upstream mining sector on which the nation’s prosperity rests.
Gina Rinehart, named The Australian Financial Review Business Person of the Year, demanded a cut to taxes, while Boris Johnson spoke in defence of Donald Trump.